Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Pathology, Research and Practice
|
July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer
Viktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer
Doris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Gynecologic Oncology
|
January 12, 2020
High homogeneity of MMR deficiency in ovarian cancer
Christoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Aging
|
September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
Stefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Oncotarget
|
November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancer
Martina Kluth, Nina Nadine Amschler, Rami Galal, et al.
Scientific Reports
|
August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Asmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Urologic Oncology
|
November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival
Till Eichenauer, David C Bannenberg, Martina Kluth, et al.
Scientific Reports
|
May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Asmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology
|
February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancer
Andrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis
|
November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
Waldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Pathology, Research and Practice
|
July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer
Viktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer
Doris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Gynecologic Oncology
|
January 12, 2020
High homogeneity of MMR deficiency in ovarian cancer
Christoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Aging
|
September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
Stefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
Oncotarget
|
November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancer
Martina Kluth, Nina Nadine Amschler, Rami Galal, et al.
Scientific Reports
|
August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Asmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Urologic Oncology
|
November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival
Till Eichenauer, David C Bannenberg, Martina Kluth, et al.
Scientific Reports
|
May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Asmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology
|
February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancer
Andrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis
|
November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
Waldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Page
of 12